Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Yellow Fever Vaccine in Atopic Dermatitis
NCT00723489Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2008
- Primary completion
- Apr 2011
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of 17D yellow fever vaccine in yellow fever, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2008; status: completed.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT00723489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723489.